Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver ( AFEF )

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      Institut Curie Paris; Université de Versailles Saint-Quentin-en-Yvelines (UVSQ); Université Paris-Saclay; Hôpital Haut-Lévêque CHU Bordeaux; CHU Bordeaux; BoRdeaux Institute in onCology (Inserm U1312 - BRIC); Université de Bordeaux (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM); Pôle Maladies de l'appareil digestif CHU Toulouse; Centre Hospitalier Universitaire de Toulouse (CHU Toulouse); Université Toulouse III - Paul Sabatier (UT3); Université de Toulouse (UT); Institute for Translational Research in Inflammation - U 1286 (INFINITE); Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille); Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille); University of Auckland Auckland; CHI Créteil; Hôpital Cochin AP-HP; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP); Polyclinique Bordeaux Nord Aquitaine (PBNA); CRLCC Eugène Marquis (CRLCC); UNICANCER; Oncogenesis, Stress, Signaling (OSS); Université de Rennes (UR)-CRLCC Eugène Marquis (CRLCC); UNICANCER-UNICANCER-Institut National de la Santé et de la Recherche Médicale (INSERM); Hôpital Bicêtre AP-HP, Le Kremlin-Bicêtre; CHU Tenon AP-HP; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU); Sorbonne Université (SU); CHU Limoges; Hôpital privé Jean Mermoz Lyon; Hôpital Paul Brousse; Institut mutualiste Monsouris (IMM); Hôpital Beaujon AP-HP; Université Paris Cité (UPCité); Centre de Recherche Interdisciplinaire / Center for Research and Interdisciplinarity Paris, France (CRI); Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité); Hôpital Saint-Joseph Marseille; Hôpital Avicenne AP-HP; None
    • بيانات النشر:
      HAL CCSD
      Wiley-Blackwell
    • الموضوع:
      2024
    • Collection:
      Université de Rennes 1: Publications scientifiques (HAL)
    • نبذة مختصرة :
      International audience ; Intrahepatic cholangiocarcinoma (iCCA) is the second most common malignant primary liver cancer. iCCA may develop on an underlying chronic liver disease and its incidence is growing in relation with the epidemics of obesity and metabolic diseases. In contrast, perihilar cholangiocarcinoma (pCCA) may follow a history of chronic inflammatory diseases of the biliary tract. The initial management of CCAs is often complex and requires multidisciplinary expertise. The French Association for the Study of the Liver wished to organize guidelines in order to summarize the best evidence available about several key points in iCCA and pCCA. These guidelines have been elaborated based on the level of evidence available in the literature and each recommendation has been analysed, discussed and voted by the panel of experts. They describe the epidemiology of CCA as well as how patients with iCCA or pCCA should be managed from diagnosis to treatment. The most recent developments of personalized medicine and use of targeted therapies are also highlighted.
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/38967424; PUBMED: 38967424
    • الرقم المعرف:
      10.1111/liv.15948
    • الدخول الالكتروني :
      https://hal.science/hal-04647913
      https://hal.science/hal-04647913v1/document
      https://hal.science/hal-04647913v1/file/Liver%20International%20-%202024%20-%20Neuzillet%20-%20Management%20of%20intrahepatic%20and%20perihilar%20cholangiocarcinomas%20Guidelines%20of%20the.pdf
      https://doi.org/10.1111/liv.15948
    • Rights:
      http://creativecommons.org/licenses/by-nc-nd/ ; info:eu-repo/semantics/OpenAccess
    • الرقم المعرف:
      edsbas.828B407E